Holen Sie sich die Stockscreener-App
208.45
1.27%
2.61
Handel nachbörslich:
207.05
-1.40
-0.67%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RMD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Resmed Inc Aktie (RMD) Neueste Nachrichten
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Ord Minnett - The Globe and Mail
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Macquarie - The Globe and Mail
ResMed CEO Farrell Exercises Options and Trims Stake Under 10b5-1 Plan - TipRanks
ResMed (RMD) After Russell Growth Index Exits Is The Undervalued Narrative Still Intact - simplywall.st
ResMed Analyst Backs Portfolio Reset - Benzinga
ResMed's Q4 2026 Earnings: What to Expect - Yahoo Finance
What Are The Latest Key Statistics for ResMed (ASX:RMD) Shares? - Kalkine
ResMed chairman & CEO Michael Farrell sells $1.09m in company stock - Investing.com Nigeria
Form 4 ResMed Inc For: 9 July By Investing.com - Investing.com Canada
Resmed Insider Sold Shares Worth $1,090,771, According to a Recent SEC Filing - marketscreener.com
ResMed (RMD) CEO Michael Farrell sells 4,991 shares under 10b5-1 plan - Stock Titan
ResMed Inc. highlights sleep and respiratory focus as investors track Nasdaq-listed shares - Ad-hoc-news.de
ResMed's Sale of MatrixCare Shows Willingness to Recycle Capital From Rationalizing Underperforming Units, Jarden Says - marketscreener.com
ResMed to sell MatrixCare business to Frazier Healthcare Partners - MSN
ResMed's billion-dollar blowup - intelligentinvestor.com.au
ResMed's $490M Sale Looks Strategically Sound -- Market Talk - Moomoo
ResMed Inc. stock falls Wednesday, underperforms market - MSN
Is ResMed Inc (RMD) a Bargain After 6.3% Drop? GF Value Says Und - GuruFocus
Resmed Agrees to Sell its Software Business to a Private Equity Firm - Medical Product Outsourcing
Why ResMed Is Dropping 5.7%: RBC Capital Maintains Outperform - AlphaStreet
ResMed (NYSE:RMD): Why The Market Is Watching? - Kalkine Media
Resmed to sell MatrixCare for $490M to private equity firm - RamaOnHealthcare
ResMed Inc. focuses on sleep and respiratory care. Long-term demand supports the business model. - AD HOC NEWS
ResMed stock held at Hold by Needham as MatrixCare sale announced - Investing.com Nigeria
ResMed's $490 Million Sale of MatrixCare Not Material to Outlook, RBC Says - marketscreener.com
RBC Capital Maintains ResMed(RMD.US) With Buy Rating, Cuts Target Price to $276 - Moomoo
Frazier Healthcare Partners Acquires MatrixCare - Hospice News
Resmed sharpens sleep care focus with $490m software business sale - Yahoo Finance
A Quick Look at Today's Ratings for ResMed(RMD.US), With a Forecast Between $225 to $320 - Moomoo
ResMed Sells MatrixCare Software Business For $490m In Portfolio Overhaul - insights.citeline.com
Wells Fargo Adjusts Price Target on ResMed to $225 From $227 - marketscreener.com
RBC Capital Cuts ResMed Price Target to $276 From $321, Maintains Outperform Rating - marketscreener.com
ResMed Inc (NYSE:RMD) Builds on a Quality Foundation with Strong Profitability and Cash Conversion - ChartMill
ResMed Is Maintained at Equal-Weight by Wells Fargo - Moomoo
Health Care Roundup: Market Talk - Moomoo
Australian Shares Fall; ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $490 Million - Moomoo
ResMed to Divest MatrixCare Business for $490 Million to Focus on Sleep and Connected Care Markets - Kalkine
ResMed Bull Sees Divestment Sharpening Strategic Focus -- Market Talk - Moomoo
ResMed's MatrixCare Sale May Hint at AI Disruption Risk -- Market Talk - Moomoo
ResMed sharpens core focus with US$490 million MatrixCare sale - Proactive financial news
Frazier Healthcare Partners to acquire MatrixCare from ResMed - MSN
Australia's ResMed sells MatrixCare business for $490M - grafa.com
ResmedReiterates Q4 FY2026 Outlook for Net - Moomoo
What Does ResMed's (ASX:RMD) MatrixCare Sale Mean for Its Future Growth Strategy? - Kalkine Media
Resmed (RMD) Sells MatrixCare to Frazier Healthcare Partners - GuruFocus
ResMed’s $490m MatrixCare sale: What it means - The Motley Fool Australia
ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $490 Million - Moomoo
ResMed to sell software business MatrixCare for $490 million - Reuters
RMD: Frazier Healthcare Partners to Acquire MatrixCare from Resmed - GuruFocus
ResMed Sells MatrixCare to Frazier Healthcare to Focus on Sleep and Connected Home Health Markets 1 - Minichart
Resmed Sees 3Q Closing for MatrixCare Divestiture -- Company Talk - Moomoo
Frazier Healthcare Partners to Acquire MatrixCare from ResMed (R - GuruFocus
Frazier Healthcare to acquire MatrixCare from ResMed By Investing.com - Investing.com South Africa
Frazier Healthcare to acquire MatrixCare from ResMed - Investing.com
Resmed to sell MatrixCare in private equity deal - Stock Titan
ResMed to Sell MatrixCare Business to Frazier Healthcare Partners - marketscreener.com
Resmed Announces Agreement to Sell MatrixCare Business to Frazier Healthcare Partners - Quiver Quantitative
Resmed Announces Agreement to Sell MatrixCare Business - 富途牛牛
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report? - Yahoo! Finance Canada
Form 144 RESMED INC For: 7 July By Investing.com - Investing.com Nigeria
ResMed (RMD) Soars 4.2%: Is Further Upside Left in the Stock? - Yahoo Finance
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):